Peter Anevski - May 10, 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
May 10, 2023
Transactions value $
-$2,716,100
Form type
4
Date filed
5/12/2023, 04:21 PM
Previous filing
May 18, 2023
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $126K +32K +14.82% $3.95* 248K May 10, 2023 Direct
transaction PGNY Common Stock Sale -$1.14M -30.2K -12.16% $37.69 218K May 10, 2023 Direct F1, F2
transaction PGNY Common Stock Sale -$71.1K -1.85K -0.85% $38.48 216K May 10, 2023 Direct F1, F3
transaction PGNY Common Stock Sale -$284K -7.54K -11.84% $37.69 56.1K May 10, 2023 See footnote F1, F2, F4
transaction PGNY Common Stock Sale -$17.8K -462 -0.82% $38.48 55.7K May 10, 2023 See footnote F1, F3, F4
transaction PGNY Common Stock Options Exercise $126K +32K +14.82% $3.95* 248K May 11, 2023 Direct
transaction PGNY Common Stock Sale -$1.12M -30.8K -12.43% $36.46 217K May 11, 2023 Direct F1, F5
transaction PGNY Common Stock Sale -$43.8K -1.18K -0.54% $37.19 216K May 11, 2023 Direct F1, F6
transaction PGNY Common Stock Sale -$281K -7.71K -13.85% $36.46 47.9K May 11, 2023 See footnote F1, F4, F5
transaction PGNY Common Stock Sale -$10.9K -294 -0.61% $37.19 47.7K May 11, 2023 See footnote F1, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -32K -3.17% $0.00 976K May 10, 2023 Common Stock 32K $3.95 Direct F7
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -32K -3.28% $0.00 944K May 11, 2023 Common Stock 32K $3.95 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.29 to $38.27, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $38.66, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.035 to $37.02, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.32, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 These shares will become fully vested and exercisable on May 23, 2023.